Labarai

NEW YORK, Yuni 23, 2022 (GLOBE NEWSWIRE) - Reportlinker.com ya ba da sanarwar fitar da rahoton "Global Intravenous Therapy and Intravenous Access Market Girman, Raba da Rahoton Bincike na Masana'antu, Hasashen Mai Amfani da Ƙarshen, Aikace-aikace, Nau'in, Yanki, 2022-2028" - - https://www.reportlinker.com/p06283441/?utm_source=GNW Hanya mafi sauri don shigar da ruwa a cikin sassa daban-daban na jiki shine ta hanyar maganin IV. Ciwon zuciya, bugun jini, da guba duk ana magance su da wannan magani. kuma ana ba da magungunan hawan jini a cikin jini.Intravenous therapy (IV) wata hanya ce ta isar da magunguna da ruwaye a cikin jiki ta hanyar jijiya.Magungunan da ke ɗauke da bitamin da ma'adanai ana ba su ta hanyar drip na cikin jini ko kuma allura na cikin jini, ba da damar maganin ya gudana cikin sauri ta cikin jini.A cewar Scope, Gudanarwar IV shine lokacin da mai haƙuri zai iya yin amfani da wani abu da ake kira vein. a magani ko rashin abinci mai gina jiki.IV far ne na hali hanyar samar da ruwaye, kwayoyi, chemotherapy, da kuma jini transfusions zuwa dehydrated marasa lafiya.A lokacin IV gwamnatin, daban-daban IV kayan aiki irin su IV catheters, jiko famfo, immobilization na'urorin, da kuma kayan aikin gwamnati. famfo wanda ke sarrafa adadin sinadarai da za a ba wa jiki kuma ana iya sa ido cikin sauƙi. Ana sa ran maganin jijiya ta duniya da kasuwar na'urorin shiga jijiya za ta ƙaru a cikin lokacin hasashen.Yaɗuwar ciwon sukari, hauhawar haɗarin zirga-zirga, da haɓaka hanyoyin tiyata ana tsammanin za su ciyar da masana'antar gaba. Masana'antar kuma ana haifar da buƙatun buƙatun da ake buƙata don isar da magunguna. COVID-19 yana da ingantacciyar tasiri gabaɗaya akan kasuwar jiyya ta IV. Don haka, tare da karuwar adadin marasa lafiya tare da COVID-19 da ke da alaƙa da ARDS, buƙatar maganin IV da samfuran shiga cikin jini yana ƙaruwa. Abubuwan Ci gaban Kasuwa Increasing Operations and Growing Geriatric Population Yawan cututtuka daban-daban da ke buƙatar samun maganin jijiyoyin jini, cututtukan koda kamar yadda cututtukan zuciya da cututtukan zuciya ya karu a shekarun baya. kamar hawan jini, ciwon sukari, kiba da damuwa, suna buƙatar kulawa mai zurfi a lokacin zaman asibiti. A cikin 'yan shekaru masu zuwa, karuwar nauyin cututtuka na kullum irin su cututtuka na zuciya da jijiyoyin jini, ciwon daji, bugun jini, da ciwon sukari, tare da yawan tsufa, zai kara yawan buƙatar maganin jijiya. Ci gaban fasaha na ciki catheters (na gefe da tsakiya, da na'urorin haɗi) suna ba da gudummawar kayan aiki masu aminci a cikin na'urori masu aminci. mafi girma-intravenous far (IVT) Practice.Kamar yadda kiwon lafiya fasaha ne mai hadaddun horo, tare da tunani da tattaunawa a kowace rana ta hanyar kwararrun kiwon lafiya da ke da hannu a cikin kulawar haƙuri a cikin sashin kulawa mai zurfi, filin kulawa ya sami sauye-sauye masu mahimmanci saboda haɗuwa da sababbin fasahohin fasaha, da kuma yankan-baki jiko famfo ne Daya daga cikin kayan aikin fasaha don taimakawa wajen samar da mafi aminci da inganci a cikin aikin fasaha (ImpT Constravenous). stringent ka'idoji da damuwa game da rikice-rikice Ana aiwatar da tsarin ba da lasisi don sabbin ayyukan a kusa da samar da famfo da haɓakawa. Bugu da ƙari, haɓakar samfurin tunowa saboda lahani na masana'anta zai rage ɗaukar waɗannan hanyoyin kwantar da hankali. Misali, Fresenius Kabi ya tuna da Vigilant Agilia Drug Depot da Volumat MC Agilia jiko jijjiga a cikin watan Agusta 20 jiko jiko. (KVO) da sauran software kwaro.Babban cikas ga ci gaban da masana'antu shi ne rikitarwa hade da yin amfani da IV hanyoyin da IV jiko kayayyakin.End User Outlook Dangane da karshen mai amfani, kasuwar an raba shi zuwa asibitoci, asibiti tiyata cibiyoyin, da kuma clinics.The asibiti sashen zai kama mafi girma rabon kudaden shiga a cikin intravenous (IV) kasuwa a cikin karuwa a cikin jiyya da kuma venous 20. tiyata da aka yi idan aka kwatanta da cibiyoyin tiyata na asibiti da kuma dakunan shan magani. Bugu da ƙari, an danganta haɓakar kashi ga karuwar amfani da maganin jijiya a cikin asibitoci, wanda ya haɗa da maganin rigakafi na ciki, magunguna ga marasa lafiya na comatose, magungunan da ba za a iya sha da baki ba, radiyon shiga tsakani, magungunan anticancer, hemodialysis, maimaita taswirar samfurin jini ga na'urorin IV, da kuma samun damar samun jini ta hanyar jini. Ci gaban fasaha da saka hannun jari na asibiti.Aikace-aikacen Outlook Dangane da aikace-aikacen, kasuwa ya kasu kashi cikin sarrafa magunguna, samfuran tushen jini, hanyoyin abinci mai gina jiki da buffer, da tasoshin faɗaɗawa ga 'yan wasa masu girma tare da tarihin bayyanar cututtuka masu karfi a karkashin kulawa mai kyau. Wasu 'yan wasa na iya amfana daga yin amfani da mai faɗakarwa. An haramta amfani da ruwa mai ciki da kuma masu ɗaukar jini na plasma a cikin wasanni masu sarrafa WADA. Ga mafi yawan 'yan wasa, maganin IV na yau da kullum ba shine mafi kyawun zaɓi ba.Nau'in Outlook Dangane da nau'in, kasuwa an raba shi a cikin buƙatun intravenous, famfo famfo, infusions da sauran buƙatun ruwa, da sauransu. 2021, sashin catheter na ciki zai kama kaso mafi girma na kudaden shiga a cikin maganin jijiya (IV) da kasuwar samun venous. Wannan ya faru ne saboda karuwar amfani da catheters na IV yayin hanyoyin tiyata don maganin IV da kuma lokacin jigilar jini, magunguna, da sauran abubuwan gina jiki zuwa sassa daban-daban na jiki. catheter na ciki da ake amfani da su don isar da magunguna, ruwa, ko wasu hanyoyin kwantar da hankali kai tsaye zuwa cikin jini. An fi shigar da su a cikin jijiya a hannu, kodayake ana iya shigar da su cikin wuya, ƙirji, ko makwanci. 2021, Arewacin Amurka shine yanki na gaba a cikin maganin jijiya (IV) da kasuwar samun venous ta hanyar ɗaukar mafi girman rabon kudaden shiga na kasuwa. Ana iya danganta ci gaban kasuwar yanki da haɓakar adadin marasa lafiya, haɓakar haɗarin zirga-zirga, haɓakar haɓaka a cikin lamuran rauni, da haɓaka saka hannun jari na tarayya a cikin haɓaka ingantattun wuraren kiwon lafiya da kamfanonin R&D masu fa'ida. a cikin rahoton sun hada da B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Fresenius SE & Co. KGaA, Cardinal Health, Inc., Pfizer, Inc., Teleflex, Inc., Baxter International, Inc., Smiths Group PLC da AngioDynamics, Inc. Ƙaddamar da Dabarun Kasuwa a cikin Intravenous (IV). An rattaba hannu kan wata yarjejeniya don siyan Fresenius Kabi, kamfanin kula da lafiya na duniya. Sayen, wanda aka ƙera don haɗa tsarin ingantaccen jiko na Ivenix a cikin Fresenius Kabi's fayil na jiko na jiko da samfuran jiko na jiko, zai kawo samfuran samfuran samfuran zuwa asibitocin Amurka. Disamba 2021: Baxter ya samar da haɗin gwiwa tare da kamfanonin fasahar kere kere na Amurka tare da haɗin gwiwar masana'antar fasaha ta Amurka Hillrom. cimma burin hangen nesa na canza tsarin kiwon lafiya na duniya da inganta kulawar haƙuri.May 2021: Smiths Medical ya samar da haɗin gwiwa tare da kamfanin fasahar likitanci Ivenix.Ta hanyar wannan haɗin gwiwa, kamfanonin biyu suna da nufin ba da dama ga hanyoyin sarrafa jiko. Bugu da ƙari, Smiths Medical zai samar da dabarun zuba jarurruka a cikin haɗin gwiwa na dogon lokaci da aka tsara don kawo sauyi na sarrafa hada-hadar kuɗi da inganta lafiyar mai haƙuri: Afrilu 2. kaddamar da wani sabon shirin, Peripheral Advantage, don inganta marasa lafiya' kwarewa tare da na gefe jijiya therapy.Shirin ya haɗu da asibiti jagora, data-kore ilhami, da ingantattun kayan aiki don ƙarfafa ma'aikatan aikin jinya don cimma nasarar farko-hannun nasara da kuma taimakawa wajen kauce wa hadaddun hade da na gefe IV therapy.Yuli 2019: Baxter ya karbi US Food and Drug Administration (FDA) don yarda da insulin nan da nan. jiko na ciki a asibitoci da sauran saitunan kulawa mai zurfi kuma yana da tsawon rayuwar kwanaki 30 ko watanni 24 a dakin da zafin jiki idan an sanyaya shi a cikin marufi na asali don tabbatar da kariya daga haske. Pumps • Hypodermic Needles • Tashar jiragen ruwa da za a dasa • Sauran ta Geography • Arewacin Amurka o USo Canadao Mexico Sauran Arewacin Amurka • Turai Jamus o UKo Faransa Rasha Spain Italiya o Sauran Turai • Asiya Pacific China o Japan Indiya Koriya Singapore Malaysia o Sauran Asiya Pacific • LAMEAo Brazil Argentina UAE Saudi Arabia South Africa Nigeria LAMEA Rest Company Profile • B. Braun Melsungen Co. Kgaa Cardinal, Cardinal Lafiya, Inc. • TeleFlex, Inc. https://www .reportlinker.com/p06283441/?utm_source=GNWAbout ReportlinkerReportLinker shine mafita na binciken kasuwa mai nasara.Reportlinker ya samo kuma ya tsara sabbin bayanan masana'antu don ku sami duk binciken kasuwa da kuke buƙata nan da nan a wuri guda.